Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Advances Drug Regulatory Reform amid Slowing Growth
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on recent pharma market data showing slower growth in 2017 a... (12/29/2017)
   
Action Plan on Protection of IPRs of Foreign-Invested Enterprises (1/16/2018)
China's Recent Development on Granting Biological Sequence Claims (1/11/2018)
CFDA Seeks Comments on the Amendments of Administrative Measures for Drug Registration (1/11/2018)
New Circular Further Enhancing the Development of the MAH Regime (1/9/2018)
Amendments Of Anti-Unfair Competition Law (1/4/2018)
China FDA Solicits Comments on Conditional Approvals for New Drugs and Compassionate Use of Investigational Drugs (1/2/2018)
China Advances Drug Regulatory Reform amid Slowing Growth (12/29/2017)
How to Protect Trade Secrets in China When Employees Leave (12/28/2017)
New Circular Further Enhancing the Development of the Market Authorization Holder Regime (12/28/2017)
Why Is China Seeing A Huge Increase in Breast Cancer Rates (12/26/2017)
Hospitals' Cost-Cutting Efforts Have Netizens Sick With Worry (12/26/2017)
GMP Certificate Cancellation in China: Concern Or Relief? (12/21/2017)
Examination Practice of Antibody-Related Patent Applications In China (12/20/2017)
Patent Issues for Life Science Companies in China (12/19/2017)
Legal Debriefs: The Revised Administrative Measures for Drug Registration (Draft For Comment) (12/19/2017)
Overview of Chinese Drug Approvals in 20...  (1/15/2018)
Type 1 Diabetes on the Rise in China, Mo...  (1/15/2018)
CFDA Releases List of Newly Approved Pro...  (1/15/2018)
CDE Publishes Notice for Office Move  (1/15/2018)
BeiGene and Mirati Announce Exclusive Li...  (1/12/2018)
Hengrui and Arcutis Announce Partnership...  (1/12/2018)
Ferring and the Chinese Academy of Scien...  (1/12/2018) (free)
Recent Executive Moves  (1/11/2018)
Ten Contemporary Chinese Biopharma Indus...  (1/11/2018)
Fosun's Wanbang Pharma and Bial Enter Ex...  (1/11/2018)
Data Snapshot: Chinese Hospital Consumpt...  (1/10/2018)
Indigenously-developed Class 1 New Chemi...  (1/10/2018)
CPIIC: Chinese Urban Hospital Drug Marke...  (1/10/2018)
Numerous Provinces Expand Disease Group-...  (1/10/2018)
Sinobioway Sunterra Biotech to Initiate ...  (1/9/2018) (free)
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
Data Snapshot: Chinese Hospital Consumption of Cholesterol-Redu...
CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat i...
Review of Chinese Pharmaceutical Distribution Sector Performanc...
SMEI: Chinese Hospital Drug Market Growth Continued to Slide in...
IQVIA: Hospital Market Share Rebounded with Flat Primary Health...
BeiGene and Mirati Announce Exclusive License Agreement for ...
Hengrui and Arcutis Announce Partnership for Novel Immune-Me...
Ferring and the Chinese Academy of Sciences Collaborate to A...
Ten Contemporary Chinese Biopharma Industry Predictions in 2...
Fosun's Wanbang Pharma and Bial Enter Exclusive Licensing Ag...
CFDA Releases List of Newly Approved Professional Journa...
CDE Publishes Notice for Office Move
CFDA Issues Guide for Development of Supplemental Drug T...
CFDA Approves 29 More Medical Institutions as Designated...
CFDA Solicits Comments on Drug Data Management Guideline...
WIPO: China Leads Innovation by Quantity
Novartis Lost Gleevec Infringement Lawsuit in China against ...
NDRC Corrects Government Monopoly Violatoins in Pharmaceutic...
Shanghai Fines Chiesi Subsidiary for Organizing Tours for Ph...
Draft Basic Healthcare and Health Promotion Law Submitted fo...
Fast Rising Price of Chinese APIs Puts Pressure on Botto...
China to Restrict Production of API Producers in 28 Citi...
Asymchem Labs Announces 2nd TGA Inspection of Its Jilin ...
French Authority Warns Chongqing API Producer over GMP V...
Another Chinese API Producer in Data Integrity Mudpool a...
Overview of Chinese Drug Approvals in 2017
Indigenously-developed Class 1 New Chemical Drugs Approv...
Sinobioway Sunterra Biotech to Initiate Trial of Two AB-...
Ascentage Announces IND Acceptance by CFDA for Clinical ...
Cantargia Granted Chinese Patent for Antibody Treatment ...
Type 1 Diabetes on the Rise in China, Most New Cases in ...
Numerous Provinces Expand Disease Group-Based BMI Paymen...
NHFPC Outlines Ten Areas of Reform Action in the New Yea...
More Young People Suffering from Colorectal Cancer in Ch...
Harvard Researchers Develop New System to Improve Health...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
CASS: Chinese Economy May See 25% Drop without Populatio...
Upcoming Event: Alzheimer 2018
Upcoming Event: 2nd World Congress on Radiology &...
Upcoming Event: Nursing 2018
Upcoming Event: Analytical Techniques 2018
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links